184 related articles for article (PubMed ID: 34075144)
1. Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors.
Gai MT; Adi D; Chen XC; Liu F; Xie X; Yang YN; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
Sci Rep; 2021 Jun; 11(1):11450. PubMed ID: 34075144
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic polymorphisms of PCSK9 with type 2 diabetes in Uygur Chinese population.
Wang MM; Lu CF; Yan SQ; Wang BZ; Yesitayi G; Tian YL; Xiang-Ma ; Ma YT
BMC Cardiovasc Disord; 2022 Jun; 22(1):284. PubMed ID: 35733117
[TBL] [Abstract][Full Text] [Related]
3. Association study of
Devi K; Bhargave A; Ahmad I; Yadav A; Gupta R
Ann Hum Biol; 2023 Feb; 50(1):56-62. PubMed ID: 36695028
[TBL] [Abstract][Full Text] [Related]
4. PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort.
Ferreira JP; Xhaard C; Lamiral Z; Borges-Canha M; Neves JS; Dandine-Roulland C; LeFloch E; Deleuze JF; Bacq-Daian D; Bozec E; Girerd N; Boivin JM; Zannad F; Rossignol P
J Am Heart Assoc; 2020 Apr; 9(7):e014758. PubMed ID: 32208829
[TBL] [Abstract][Full Text] [Related]
5. PCSK9 genetic (rs11591147) and epigenetic (DNA methylation) modifications associated with PCSK9 expression and serum proteins in CAD patients.
Shyamala N; Gundapaneni KK; Galimudi RK; Tupurani MA; Padala C; Puranam K; Kupsal K; Kummari R; Gantala SR; Nallamala KR; Sahu SK; Hanumanth SR
J Gene Med; 2021 Aug; 23(8):e3346. PubMed ID: 33885177
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms rs562556 and rs2479409 of the PCSK9 gene associated with obesity and cardiovascular disease.
Vašková H; Poráčová J; Šlebodová M; Kalafutová S; Konečná M; Sedlák V; Kimáková T; Mydlárová Blaščáková M
Cent Eur J Public Health; 2023 Dec; 31(Suppl 1):S82-S88. PubMed ID: 38272483
[TBL] [Abstract][Full Text] [Related]
7. Association between Apo B, LDL-R and PCSK9 gene polymorphisms with coronary artery diseases in Egyptians.
Mahsoub N; Almenshawy A; Taki Eldin AM; Abdel Hay NM; Youssef AR; El-Farahaty RM; El-Sayed K; Osman AM; Elhennawy ES
Mol Biol Rep; 2024 Jun; 51(1):752. PubMed ID: 38874786
[TBL] [Abstract][Full Text] [Related]
8. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
[TBL] [Abstract][Full Text] [Related]
9. Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels.
Guo T; Yin RX; Huang F; Yao LM; Lin WX; Pan SL
Sci Rep; 2016 Jan; 6():19079. PubMed ID: 26744084
[TBL] [Abstract][Full Text] [Related]
10. PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort.
Small AM; Huffman JE; Klarin D; Lynch JA; Assimes T; DuVall S; Sun YV; Shere L; Natarajan P; Gaziano M; Rader DJ; Wilson PWF; Tsao PS; Chang KM; Cho K; O'Donnell CJ; Casas JP; Damrauer SM;
PLoS One; 2020; 15(11):e0239752. PubMed ID: 33166319
[TBL] [Abstract][Full Text] [Related]
11. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan.
Hsu LA; Teng MS; Ko YL; Chang CJ; Wu S; Wang CL; Hu CF
Clin Chem Lab Med; 2009; 47(2):154-8. PubMed ID: 19191720
[TBL] [Abstract][Full Text] [Related]
12. The association of cholesterol absorption gene Numb polymorphism with Coronary Artery Disease among Han Chinese and Uighur Chinese in Xinjiang, China.
Abudoukelimu M; Fu ZY; Maimaiti A; Ma YT; Abudu M; Zhu Q; Adi D; Yang YN; Li XM; Xie X; Liu F; Chen BD
Lipids Health Dis; 2015 Sep; 14():120. PubMed ID: 26415596
[TBL] [Abstract][Full Text] [Related]
13. Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population.
Cai G; Yu L; Huang Z; Li L; Fu X
Lipids Health Dis; 2018 Sep; 17(1):213. PubMed ID: 30205809
[TBL] [Abstract][Full Text] [Related]
14. The significance of PCSK-9's level and polymorphism in premature coronary artery disease: Relation to risk and severity.
Gaber MA; Omar OHM; Meki AMA; Nassar AY; Hassan AKM; Mahmoud MS
Clin Biochem; 2024 Mar; 125():110729. PubMed ID: 38342398
[TBL] [Abstract][Full Text] [Related]
15. Molecular population genetics of PCSK9: a signature of recent positive selection.
Ding K; Kullo IJ
Pharmacogenet Genomics; 2008 Mar; 18(3):169-79. PubMed ID: 18300938
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome.
Xavier LB; Sóter MO; Sales MF; Oliveira DK; Reis HJ; Candido AL; Reis FM; Silva IO; Gomes KB; Ferreira CN
Gene; 2018 Feb; 644():129-136. PubMed ID: 29109005
[TBL] [Abstract][Full Text] [Related]
17. Acyl-CoA: cholesterol acyltransferases-2 gene polymorphism is associated with increased susceptibility to coronary artery disease in Uygur population in Xinjiang, China.
Wang YT; Maitusong B; Ma YT; Fu ZY; Yang YN; Ma X; Li XM; Liu F; Chen BD
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30696703
[TBL] [Abstract][Full Text] [Related]
18. Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality.
Benn M; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2019 Jun; 73(24):3102-3114. PubMed ID: 31221259
[TBL] [Abstract][Full Text] [Related]
19. A novel study to examine the association of
Reddy S; Kaur N; Singh J
J Genet; 2018 Dec; 97(5):1371-1378. PubMed ID: 30555085
[TBL] [Abstract][Full Text] [Related]
20.
Mohamed SH; Hassaan MMM; Ibrahim BA; Sabbah NA
Genet Test Mol Biomarkers; 2021 Sep; 25(9):615-623. PubMed ID: 34550777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
